You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. The assets of failed DNA testing firm 23andMe are being bought for $256 million. Biotechnology firm ...

Add Futurism (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results. Biotech ...

Regeneron Pharmaceuticals has agreed to acquire nearly all of 23andMe’s assets for $256 million, including its genetic data, following a bankruptcy auction. The deal still needs to be approved by the ...

23andMe announced on Monday it would cut 40% of its workforce, representing more than 200 employees, as part of a restructuring at the company. The genetic testing company is also discontinuing its ...

DNA and genetic testing firm 23andMe is in turmoil following a 2023 data breach and its ongoing financial decline. The once-pioneering giant now faces an uncertain future as bankruptcy looms over the ...

Anne Wojcicki, once the face of biotech’s consumer revolution, holding a Breakthrough Prize. Years later, 23andMe has filed for bankruptcy—taking 99.8 percent of its value and the genetic data of 15 ...

23andMe will keep offering customers its DNA testing services after being bought out of bankruptcy. New York-based biotech company Regeneron Pharmaceuticals announced an agreement on Monday to ...

Matthew Herper covers medical innovation — both its promise and its perils. 23andMe, the genetics startup that has repeatedly captured the public imagination and then faced nearly fatal business ...

David Siffert, legal director at S.T.O.P., discusses 23andMe’s possible bankruptcy along with the potential legal fallout and the privacy threat it poses to our genetic data. By now, multiple sources ...

Regeneron Pharmaceuticals will acquire 23andMe's assets for $256 million, both companies said. 23andMe filed for Chapter 11 bankruptcy earlier this year. The DNA testing company has faced major ...

The bankrupt DNA testing firm is being sold to the highest bidder for $256 million. The bankrupt DNA testing firm is being sold to the highest bidder for $256 million. is a news writer focused on ...